Experimental allergic encephalomyelitis: Neutralizing antibody to TGFβ1 enhances the clinical severity of the disease

This publication has 44 references indexed in Scilit:

• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
  Nature, 1992
• Transforming Growth Factors β1 and α in Chronic Liver Disease
  New England Journal of Medicine, 1991
• The T Lymphocyte in Experimental Allergic Encephalomyelitis
  Annual Review of Immunology, 1990
• Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-α
  Journal of Neuroimmunology, 1990
• Transforming growth factors β1 and β2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function
  Journal of Neuroimmunology, 1989
• Regulation of experimental autoimmune encephalomyelitis
  Journal of Neuroimmunology, 1989
• Anti-Idiotypic Network Induced by T Cell Vaccination Against Experimental Autoimmune Encephalomyelitis
  Science, 1988
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1987
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.
  The Journal of Experimental Medicine, 1986
• The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis
  European Journal of Immunology, 1981